2 messages
MDT
Medtronic (MDT): Growth Outpaced by Margin Challenges
Aug 19, 2025, 06:04 PM
Quarterly Post-Earnings Summary
Medtronic delivered solid Q1 FY2026 revenue growth, but persistent margin pressures and flat EPS continue to weigh on near-term investor sentiment despite innovation and a strong balance sheet.
MDT
Medtronic (MDT): Margin Upside Amid Segment Strength
Aug 17, 2025, 12:06 PM
Earnings Outlook
Medtronic is poised for Q1 FY2026 margin and revenue upside, driven by strong segment growth and new product launches, though the diabetes spin-off may introduce short-term volatility.